You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

Details for Patent: 9,662,398


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,662,398 protect, and when does it expire?

Patent 9,662,398 protects ILEVRO and is included in one NDA.

This patent has fifty-four patent family members in twenty-six countries.

Summary for Patent: 9,662,398
Title:Carboxylvinyl polymer-containing nanoparticle suspensions
Abstract: The present invention generally relates to suspension compositions having a carboxyvinyl polymer such as a carbomer, a galactomannan such as guar, and a borate compound. A sparingly soluble particulate compound such as nepafenac is also included in the compositions. The sparingly soluble particulate compound has a small particle size to enhance bioavailability of the compound.
Inventor(s): Chowhan; Masood A. (Arlington, TX), Ghosh; Malay (Fort Worth, TX), Asgharian; Bahram (Arlington, TX), Han; Wesley Weshin (Arlington, TX)
Assignee: Alcon Research, Ltd. (Fort Worth, TX)
Application Number:14/539,996
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,662,398
Patent Claim Types:
see list of patent claims
Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,662,398

To delve into the specifics of United States Patent 9,662,398, it is crucial to understand the broader context of patent law, the process of patent granting, and the tools available for analyzing patent data.

Overview of the USPTO and Patent Process

The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. The patent process involves several stages, including filing, examination, and potential appeals if the patent is rejected[1].

Patent Claims and Scope

Patent claims are the heart of a patent, defining the scope of the invention for which protection is sought. The USPTO provides extensive datasets and tools to analyze these claims. For instance, the Patent Claims Research Dataset contains detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset helps in understanding the dependency relationships between claims and provides statistics on claim-level and document-level data[3].

Analyzing Patent 9,662,398

Patent Details

To analyze the specific patent, one would start by searching for the patent number using the USPTO's Patent Public Search tool or other search resources like the Global Dossier or the Patent and Trademark Resource Centers (PTRCs)[4].

Claims Analysis

The claims section of the patent is critical as it outlines what the inventor is seeking to protect. Here are some key points to consider:

  • Independent and Dependent Claims: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.
  • Claim Language: The language used in the claims must be clear and specific to avoid ambiguity and ensure enforceability.
  • Scope of Protection: The claims determine the scope of protection granted by the patent. Broader claims may offer more protection but are also more likely to be challenged.

Prior Art and Novelty

To assess the novelty and non-obviousness of the invention, one must conduct a thorough search of prior art. Tools like the Common Citation Document (CCD) and international patent databases can help in identifying relevant prior art cited by various patent offices[4].

Patent Landscape

Understanding the patent landscape involves analyzing the broader field of technology related to the patent. This includes identifying key players, trends, and existing patents in the same or related fields. The USPTO's Economic Working Papers, such as "Patent Claims and Patent Scope," provide insights into patent scope measurements and trends[3].

Tools for Analysis

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching existing patents and published patent applications. It replaces legacy search tools and offers enhanced access to prior art[4].

Global Dossier

The Global Dossier provides access to the file histories of related applications from participating IP Offices, allowing users to see the patent family for a specific application and related data[4].

Consultative Groups and Expert Input

For complex analyses, consultative groups of academic experts and legal practitioners can provide valuable insights. For example, the study on a potential small claims patent court involved a wide range of stakeholders and experts to ensure comprehensive input[2].

Case Studies and Legal Precedents

Bhagat v. PTO

The case of Bhagat v. PTO highlights the importance of clear and specific claim language. The court's decision to affirm the rejection of certain claims due to obviousness and lack of specific arguments underscores the need for thorough preparation and argumentation in patent applications[5].

Key Takeaways

  • Clear Claim Language: Ensure that the claims are clear, specific, and well-defined to avoid ambiguity and potential challenges.
  • Thorough Prior Art Search: Conduct a comprehensive search of prior art to establish the novelty and non-obviousness of the invention.
  • Use of Advanced Tools: Utilize tools like the Patent Public Search, Global Dossier, and consultative groups to gain a deeper understanding of the patent landscape.
  • Legal Precedents: Be aware of legal precedents and court decisions that can impact the validity and enforceability of patent claims.

FAQs

1. What is the role of the USPTO in the patent process?

The USPTO is responsible for granting U.S. patents and registering trademarks, overseeing the entire process from application to issuance.

2. How do I search for existing patents?

You can use the USPTO's Patent Public Search tool, Global Dossier, or visit the Public Search Facility and Patent and Trademark Resource Centers (PTRCs) for assistance[4].

3. What are the key components of a patent claim?

Key components include independent and dependent claims, clear and specific language, and a well-defined scope of protection.

4. Why is prior art search important?

Prior art search is crucial to establish the novelty and non-obviousness of the invention, ensuring that the patent is valid and enforceable.

5. What resources are available for analyzing patent data?

Resources include the Patent Claims Research Dataset, Economic Working Papers from the USPTO, and tools like the Common Citation Document (CCD) and international patent databases[3][4].

Sources

  1. U.S. Patent and Trademark Office (USPTO) | USAGov https://www.usa.gov/agencies/u-s-patent-and-trademark-office

  2. U.S. Patent Small Claims Court https://www.acus.gov/research-projects/us-patent-small-claims-court

  3. Patent Claims Research Dataset - USPTO https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset

  4. Search for patents - USPTO https://www.uspto.gov/patents/search

  5. BHAGAT v. PTO - Court of Appeals for the Federal Circuit https://cafc.uscourts.gov/opinions-orders/23-1545.OPINION.4-3-2024_2295461.pdf

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,662,398

Showing 1 to 1 of 1 entries

International Family Members for US Patent 9,662,398

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 080572 ⤷  Try for Free
Argentina 122463 ⤷  Try for Free
Australia 2010326099 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.